Drug Therapy for Nausea and Vomiting: Medical Terminology and Clinical Concepts

Chapter 38: Drug Therapy for Nausea and Vomiting

Introduction

Nausea and vomiting (N/V) are common symptoms associated with a variety of medical conditions and treatments. Understanding the causes, physiology, and management—including pharmacologic and nonpharmacologic interventions—is essential for effective patient care. This chapter provides an overview of the terminology, mechanisms, and clinical approaches to N/V, with a focus on drug therapy and nursing interventions.

Causes of Nausea and Vomiting

Gastrointestinal (GI) Disorders

• GI tract infection and inflammation: Conditions such as gastroenteritis, hepatitis, and pancreatitis can trigger N/V.

• Impaired GI motility and muscle tone: Disorders like gastroparesis or obstruction may lead to N/V.

• Dietary factors: Overeating or consuming irritating foods or fluids can provoke symptoms.

Other Systemic Causes

• Cardiovascular disorders: Myocardial infarction and heart failure may present with N/V.

• Infectious disorders: Systemic infections can induce N/V as part of the illness.

• Neurologic disorders: Increased intracranial pressure, migraines, and vestibular dysfunction are notable causes.

• Metabolic disorders: Conditions such as diabetic ketoacidosis or uremia may result in N/V.

• Drug therapy: Many medications list N/V as a common adverse effect.

Additional Triggers

• Noxious stimuli: Pain, unpleasant sights, and odors can provoke N/V.

• Emotional and physical stress: Psychological factors may contribute.

• Radiation therapy and motion sickness: Both can stimulate the vomiting center.

• Postoperative status and pregnancy: N/V is common after surgery and during pregnancy (morning sickness).

• Migraines: Frequently associated with N/V.

Medical Terminology: Nausea and Vomiting

• Nausea: An unpleasant sensation of abdominal discomfort with a desire to vomit.

• Vomiting (Emesis): The forceful expulsion of stomach contents through the mouth.

• Antiemetics: Medications used to prevent or treat nausea and vomiting.

Physiology of Nausea and Vomiting

• Vomiting Center: Located in the medulla oblongata; coordinates the act of vomiting.

• Chemoreceptor Trigger Zone (CTZ): Detects emetogenic substances in the blood and cerebrospinal fluid; activation leads to stimulation of the vomiting center.

• Vestibular Apparatus: Inner ear receptors involved in motion sickness.

• Other Inputs: Cerebral cortex and sensory organs can also send signals to the vomiting center.

Example: In pregnancy, the CTZ is particularly sensitive, leading to morning sickness. In motion sickness, the vestibular apparatus is the primary trigger.

Pharmacologic Management: Antiemetic Drug Classes

Phenothiazines

• Prototype: Promethazine

• Mechanism: Central nervous system (CNS) depressant; blocks dopamine receptors in the CTZ.

• Uses: Prevention and treatment of N/V from various causes.

• Common Side Effects: Blurred vision, urinary retention, dry mouth, photosensitivity, drowsiness, confusion, orthostatic hypotension, exacerbation of asthma, and ECG changes (Q wave and T wave alterations).

Antihistamines

• Prototype: Hydroxyzine

• Mechanism: H1 receptor blocker; prevents histamine effects on tissues.

• Uses: Classic antihistamines are used as antiemetics, especially for motion sickness.

• Adverse Effects: Drowsiness, dizziness, confusion, dry mouth, thickened respiratory secretions, blurred vision, urinary retention, tachycardia, prolonged QT interval, and risk of torsades de pointes.

5-HT3 Receptor Antagonists

• Prototype: Ondansetron

• Mechanism: Blocks serotonin (5-HT3) receptors in the CTZ and GI tract.

• Uses: First-line for acute emesis from chemotherapy and postoperative N/V.

• Adverse Effects: Diarrhea, headache, dizziness, constipation, fatigue, transient liver enzyme elevation, and injection site pain.

Substance P/Neurokinin 1 Antagonists

• Prototype: Aprepitant

• Mechanism: Blocks neurokinin 1 (NK1) receptors in the brain, inhibiting substance P.

• Uses: Prevents acute and delayed chemotherapy-induced N/V.

• Adverse Effects: Fatigue, weakness, dizziness, abnormal heart rhythm, headache, hiccups, and infusion site pain (IV).

Nonpharmacologic Techniques

• Acupuncture and Acupressure: Stimulation of specific points may reduce N/V.

• Herbal Supplements: Ginger and other herbs are sometimes used as adjuncts.

Assessment of Nausea and Vomiting

• Identify risk factors (e.g., underlying disorders, medications).

• Interview about frequency, duration, and triggers of N/V.

• Assess accompanying symptoms and characteristics of vomitus (amount, color, odor, presence of blood).

• Observe and measure vomitus when possible.

Nursing Interventions for Nausea and Vomiting

Prevention and Minimization

• Help patients identify and avoid triggers (e.g., unpleasant sights, odors, certain foods, alcohol, NSAIDs).

• Administer analgesics before painful procedures to reduce pain-induced N/V.

Drug Administration Strategies

• Administer antiemetics 30–60 minutes before known triggers (e.g., chemotherapy, radiation, travel).

• Adjust timing of oral drugs that cause gastric irritation; take with or after food if appropriate.

• Consult references to ensure compatibility of drugs with food.

Monitoring and Reporting

• Assess and report persistent N/V to healthcare provider; medication adjustment may be necessary.

• For GI obstruction or paralytic ileus, restrict oral intake and consider nasogastric intubation.

• For pregnancy-related N/V, suggest dry crackers before rising and small, frequent protein meals.

Acute Episode Management

• Avoid oral intake during acute N/V episodes to prevent worsening and fluid/electrolyte imbalance.

• Encourage rest and minimize activity; lying down may help reduce symptoms.

Supportive Care

• Provide replacement fluids and electrolytes as needed.

• Offer small amounts of food and fluids as tolerated.

• Monitor vital signs, intake/output, and body weight regularly.

• Reduce environmental stimuli (noise, odors) and allow rest.

Oral Care and Comfort

• Assist with mouth rinsing after vomiting to reduce bad taste and protect tooth enamel.

• Provide comfort measures (e.g., cool washcloths) and support home remedies when appropriate.

• Educate patients about their drug therapy and self-care strategies.

Table: Comparison of Antiemetic Drug Classes

Drug Class	Prototype	Mechanism	Common Uses	Key Adverse Effects
Phenothiazines	Promethazine	Blocks dopamine receptors in CTZ	General N/V, motion sickness	Drowsiness, dry mouth, hypotension, ECG changes
Antihistamines	Hydroxyzine	H1 receptor blocker	Motion sickness, allergy-related N/V	Drowsiness, dry mouth, urinary retention, QT prolongation
5-HT3 Antagonists	Ondansetron	Blocks serotonin receptors	Chemotherapy/postoperative N/V	Headache, diarrhea, constipation, liver enzyme elevation
NK1 Antagonists	Aprepitant	Blocks neurokinin 1 receptors	Chemotherapy-induced N/V	Fatigue, dizziness, abnormal heart rhythm

Key Equations and Concepts

• Fluid Balance Equation: In cases of severe vomiting, monitoring fluid balance is critical. The basic equation is: $\text{Fluid Balance} = \text{Fluid Intake} - \text{Fluid Output}$

• Electrolyte Replacement: Replacement solutions may be calculated based on losses: $\text{Replacement Volume} = \text{Estimated Losses} + \text{Maintenance Needs}$

Summary

• Nausea and vomiting are common symptoms with diverse causes, including GI, cardiovascular, neurologic, metabolic, and drug-related factors.

• Management includes both pharmacologic (antiemetic drugs) and nonpharmacologic techniques.

• Assessment and nursing interventions are essential for effective care and prevention of complications.